Bristol-myers Squibb Compnay

Naveen Kumar Dhondi

Heather J Finlay

John E Lloyd

Prashantha Gunaga

James A Johnson

James Neels

Abhisek Banerjee

Ashokkumar Adisechan

Ji Jiang

Ashok Kumar Adisechan

Srinivasu Pothukanuri

Pothukanuri Srinivasu

Kavitha Govindrajulu

Govindrajulu Kavitha

A compound of formula I wherein A, X, Y, Z, Rand Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function.

Quinazolines as potassium ion channel inhibitors

A compound of formula (I) (I) wherein A, R1, R1a, R3 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function. 

Isoquinolines as potassium ion channel inhibitors

A compound of formula (I) wherein A, R, R, and Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, maintaining normal sinus rhythm, I-associated disorders, and other disorders mediated by ion channel function.

Pyrrolotriazines as potassium ion channel inhibitors

A compound of formula (I) wherein A, X, Y, Z, Rand Rare described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, I-associated disorders, and other disorders mediated by ion channel function. 

Growing community of inventors

Secunderabad, India

Naveen Kumar Dhondi